Filing Details

Accession Number:
0001096906-22-002328
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-23 16:14:02
Reporting Period:
2020-03-19
Accepted Time:
2022-09-23 16:14:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1514946 Axim Biotechnologies Inc. AXIM Pharmaceutical Preparations (2834) 274092986
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568485 Ii Walter John Huemoeller 6191 Cornerstone Court, E.
Suite 114
San Diego CA 92121
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-19 6,000,000 $0.00 6,000,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer.